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Introduction 
Bone defects attributed to serious periodontitis, 
trauma, and injury are commonly encountered in 
the fields of dentistry, craniofacial surgery, and 
orthopedics. Although autogenous bone grafting 
is still considered the gold standard for treatment, 
this process has several drawbacks, such as the 
requirement of a second surgery and the limited 
availability of collectable bone [1]. Artificial 
bone grafts are thought to be promising alterna-
tives to autogenous bone grafts. Several calcium 
phosphate (CaP)-based biomaterials, such as 
hydroxyapatite (HA), tricalcium phosphate 
(TCP), and octacalcium phosphate (OCP), have 
been intensively investigated for use as artificial 
bone because, under appropriate conditions, 
these materials show excellent biocompatibility 
and bioactivity [2, 3].  
High-temperature TCP, known as al-
pha-tricalcium phosphate (-TCP), is often pre-
pared by the sintering of amorphous precursors 
with the proper composition [4]. Its calcium- 
to-phosphate ratio is theoretically 1.50. In gen-
eral, -TCP dissolves more easily than OCP, 
-TCP, and HA under neutral pH conditions [4]. 
Furthermore, -TCP converts to apatite in 
aqueous solution over time [5], to low-     
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Synopsis 
Alpha-tricalcium phosphate (-TCP) has been investigated extensively as an artificial bone graft;
however, the relationship between size of -TCP particles and its bone-formation capability is not
clear. In the present study, we compared the bone-formation capability of two different sized po-
rous -TCP particles (-TCP200 [under 200 m], and -TCP600 [500–600 m]) in critical-sized
bone defects in mouse calvaria up to 12 wk after implantation. Scanning electron microscopy re-
vealed that both particles possessed similar smooth surface with porous structure. Before implanta-
tion, inter-particle size and specific surface area of -TCP200 were 27 m and 0.40 m2/g and of
-TCP600 were 209 m and 0.24 m2/g, respectively. Histomorphometric analysis after implanta-
tion of the particles revealed that both particles promoted osteoconduction. At 12 wk, -TCP200
induced superior bone formation than -TCP600. At 4 wk, -TCP200 showed more hydrolysis
than -TCP600. These results indicate that the size of -TCP particles may influence their
bone-formation capability in critical-sized bone defects of mouse calvaria. This effect might be
partially due to the difference in the hydrolysis speed of different-sized particles.  
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crystalline hydroxyapatite in simulated body 
fluid [6], to fluoride-incorporated apatite in so-
dium fluoride solution [7], and to OCP in phos-
phoric acid solution [8].  
Numerous studies have been performed to 
verify the usability of -TCP for clinical appli-
cation as bone graft material [9, 10]. -TCP has 
been found to be biodegradable in rabbit cranial 
defects when used in the particle form [9] and in 
Ti-chambers when used in the porous block form 
[10]. This ceramic is known to be a component 
of self-setting calcium phosphate cements, 
which can be injected into bone defects [11]. 
-TCP is often used as a carrier for drugs, such 
as statin [12], catechin [13], and growth factors 
[14]. It provides a good environment for osteo-
genesis of MSCs [15] and osteoblastic cells [16] 
even in vitro.  
In previous studies using different CaPs, it 
has been recognized that its bone-formation ca-
pability is affected by some properties such as 
bioresobabiliy, pore size, and mechanical 
strength [17]. Particle size has also been re-
ported as a pivotal property influencing the re-
sult of bone formation [18-22]. Consistent with 
these studies, we have recently reported that dif-
ferent-sized -TCP particles with artificial 
polypeptides induced distinct bone formation in 
a mini-pig non-critical-sized skull defect model 
[1]. This finding suggested that particle size 
might be a factor modulating the bone formation 
capability of -TCP. However, our previous 
study was performed under the conditions with 
artificial polypeptides. There is still paucity of 
information about the relationship between par-
ticle size of intact -TCP particles (those not 
exposed to treatments such as hydrolysis and not 
mixed with materials such as polymers) and its 
bone-formation capability in bone defects.  
To elucidate this relationship, we investi-
gated whether size of -TCP particles without 
any intrusion, such as polypeptide, alter its 
bone-formation capability in critical-sized defect 
of mouse calvaria. Two different-sized -TCPs 
were prepared with particle size <200 m and 
500–600 m (hereafter, referred to as -TCP200 
and -TCP600, respectively). In addition, we 
also evaluated the hydrolysis behavior of the two 
-TCPs at 4 wk after implantation.  
 
Materials and methods 
1. Preparation and characterization of -TCP 
particles 
Two types of porous -TCPs with different par-
ticle sizes were kindly provided by Taihei 
Chemical Industrial Co. Ltd. (Osaka, Japan). 
The particle sizes of the two -TCPs were simi-
lar to those used in the previous study in order to 
compare the results easily [1]. A field emis-
sion-scanning electron microscope (FE-SEM; 
S-4100, Hitachi High-Technologies Corporation, 
Tokyo, Japan) was used to analyze particle size, 
pore distribution, and outer surface conditions. 
Before observation, samples were coated with 
the platinum-palladium using E-1030 (Hitachi 
High-Technologies Corporation). -TCP parti-
cles were characterized by the powder X-ray 
diffraction system (XRD; XRD-6100, Shimadzu, 
Kyoto, Japan). XRD patterns were obtained un-
der the following condition: 40.0 kV, 30.0 mA, 
scan rate 2 degree/min with a step size 0.05 de-
grees, 3–80 degrees. Crystal phase was charac-
terized with database from the International 
Centre for Diffraction Data (HA: 
9-0432;-TCP: 9-0348). Specific surface area 
(SSA) of the -TCPs was evaluated by the Bet 
method using Gemini 2360 (Shimadzu). In-
ter-particle size of -TCP particles before im-
plantation was determined by the mercury intru-
sion technique using auto pore IV 9510 (Micro-
meritics, Norcross, GA, USA).  
  
2. Implantation of -TCPs into critical-sized 
bone defect of mouse calvaria 
All in vivo experiments were conducted in ac-
cordance with the guidelines of the local animal 
ethics committee of Osaka Dental University 
and were approved by the committee (approval 
number: 12-05001). Male ICR mice (8 wk) were 
housed in a light and temperature controlled en-
vironment during the experiment. Following 
general anesthesia with intraperitoneal injection 
of sodium pentobarbital supplemented with 
isoflurane inhalation, the skin and periosteum 
was opened under the disinfection conditions. 
Next, 4.2 mm defects, which have been reported 
as critical-sized defects [23], were created at the 
calvaria by using the trephine bar (Dentech, To-
kyo, Japan) under saline irrigation so as not to 
damage the  one.  After the defects  were  filled  
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with samples or left unfilled (control), they were 
covered with 50-m Teflon sheet to stabilize the 
implants. At least 4 mice were used for each 
group. Four or 12 wk after the treatment, the 
calvaria of each mouse was obtained to for use 
in further experiments. The calvaria was par-
tially fixed with cold 4% paraformaldehyde 
phosphate buffer solution before microfocus 
X-ray computed tomography (CT) and histo-
logical analysis. Calvariae without fixation were 
used for estimating the hydrolysis behavior of 
particles in vivo.  
 
3. Micro-computed tomography 
After fixation, the specimens were evaluated 
using CT (SMX-130CT, Shimadzu). Calvariae 
were placed on the turntable using utility wax, 
and then exposed to 74 A of 48 kV radiation at 
46.8 m intervals. Images were saved at 512 × 
512 pixel. The CT images from vertical and 
lateral sides were reconstructed using the 
TRI/3D bone software (Ratoc Co. Ltd., Tokyo 
Japan). Bone mineral density (BMD) represent-
ing calcified bone tissue was evaluated using 
cylindrical phantoms containing a hydroxyapa-
tite (HA content: 200 to 800 mg/cm3). 
 
4. Histology and histomorphometric analysis 
After fixation, the samples were decalcified, 
dehydrated, and embedded in paraffin. The 
specimens were sectioned at 5 m thickness and 
used for hematoxylin-eosin staining (H-E stain-
ing). Histomorphometric analysis of bone for-
mation in the defects was conducted according 
to the method reported previously [3]. In brief, 
H-E-stained sections covering the whole defect 
were used to calculate the extent of new bone 
formation. The area of tissue showing color 
similar to that of the non-treated calvaria was 
estimated as the area of newly formed bone (NB 
area), while the whole area created by the 
trephination was considered the treated area 
(TA). Both NB and TA were analyzed using Im-
age J software (version 1.46r, NIH, USA). The 
percentage of newly formed bone was calculated 
as (NB/TA) × 100.  
 
5. Hydrolysis of -TCP particles in the bone 
defect 
At 4 wk after implantation, the particles, along 
with the tissue, were isolated without fixation. 
The complexes were grained with mortar and 
pestle, and then evaluated by XRD analysis to 
estimate the hydrolysis behavior. The particles in 
the defects of three mice were integrated in order 
to analyze the hydrolysis rate of -TCPs.  
 
6. Statistical analysis  
All data in bar graph were expressed as the mean 
with standard deviation. One-way analysis of 
variance (ANOVA) was used to compare the 
difference of the means among groups. 
Tukey-Kramer test was used as a post hoc test to 
confirm difference noted in ANOVA.  
 
Results 
1. Characterization of -TCP particles  
Fig. 1A shows the macroscopic structure of 
-TCP200 and -TCP600. We confirmed that 
fine (-TCP200) and coarse (-TCP600) parti-
cles were obtained. Consistent with this differ-
ence, -TCP200 showed larger SSA than 
-TCP600: 0.40 m2/g for -TCP200 and 0.24 
m2/g for -TCP600. Fig. 1B shows the electron 
microscopic images of -TCPs. Except for the 
difference in particle size, there was negligible 
 
Fig. 1   Macroscopic (A) and scanning electron microscopic (B) images of -TCPs. 
A-a: -TCP200; A-b: -TCP600. Bars in B: 750 m for a, b; 75 m for c, d; 10 m for e, f. 
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difference in the surface structure of the two 
particles. At high magnification, both -TCPs 
showed macropores of varying sizes and smooth 
surfaces. XRD profiles of both intact particles 
are shown in Fig. 2A. The specific peaks of 
-TCP (indicated by the triangles) were detect-
able in the XRD patterns of both particles. Inter- 
particle size (median diameter) of -TCP200 
was estimated as 27 m, while that of 
-TCP600 was 209 m (Fig. 3).  
 
2. Control group 
Fig. 4A and B show the CT (vertical and lateral 
angle) and BMD (vertical) images of the defect 
in the control group. There was no enhancement 
in the radiopacity of the defect up to 12 wk after 
implantation. Fig. 4C and D display the histo-
logical sections of defect at 12 wk. Thin connec-
tive tissue entirely covered the defect from edge 
to edge (Fig. 4D-b).  
 
 
 
Fig. 2  X-ray diffraction pattern of samples before (A) and after (B, C) the implantation. Intact: without hydrolysis
treatment (original particle). Triangles: specific peaks of -TCP. Broken squares in B show the magnified area used in C.
Arrow in C: specific peak of apatite at 32.9o. 
Fig. 3  Inter-particle size of -TCPs analyzed by the mercury intrusion technique. 
Tokuda et al.-TCP Particle Size and Bone Formation, Nano Biomedicine 7(2), 63-71, 2015 
 67
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Bone formation in defect
treated without -TCPs (control
group).  
A: vertical micro-computed tomogra-
phy (CT) and bone-mineral density
(BMD) images. B: lateral CT image.
C, D: histological sections of defect
stained with hematoxylin-eosin (H-E).
Gap of triangles: created bone defect.
Broken squares in C: magnified area
for D. 
Fig. 5Bone formation in defects
treated with -TCP200.  
A: vertical CT and BMD images. B:
lateral CT images. C, D: histological
sections of defect stained with H-E.
Broken squares in C: magnified area
for D. Gap of triangles: created bone
defect. NBs: New bones. BM: Bone
marrow. 
Fig. 6one formation in defect
treated with -TCP600.  
A: vertical CT and BMD images. B:
lateral CT images. C, D: histological
sections of defect stained with H-E.
Gap of triangles: created bone defect.
Broken squares in C: magnified area
for D.   
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3. -TCP200 
Fig. 5A and B show the CT (vertical and lateral 
angle) and BMD (vertical) images of defects 
treated with -TCP200. Strong radiopacity 
gradually covered the defects. Higher BMD, 
shown in brown, invaded from the edge of de-
fects. Fig. 5C and D shows the histological sec-
tion of the defect treated with -TCP200. Con-
sistent with the result in the BMD image, new 
bone formation increased and proceeded toward 
the center of the defects. At high magnification, 
the newly formed bone was observed to cover 
the blank white portion, possibly indicating re-
sidual -TCP particles in the defect. We could 
observe bone marrow containing blood cells in 
the newly formed bone. In addition, fibrous tis-
sue could still be observed in the center of the 
defects. 
 
4. -TCP600 
Fig. 6A and B show the CT (vertical and lateral 
angle) and BMD (vertical) images of defects 
treated with -TCP600. Although radiopacity 
could be observed in the defects up to 12 wk, its 
integration was subtle compared with that in the 
-TCP200 samples. Fig. 6C and D show the 
histological section of defects treated with 
-TCP600. The blank white portion covered by 
cells possibly indicates residual -TCP600 par-
ticles in the defect. Large -TCP600 particles 
were still visible (Fig. 6D-a). Despite cell inva-
sion, there was no remarkable ingrowth of bone 
toward the center of the defect. New bone for-
mation was limited to the edge of the defect (Fig. 
6D-b). 
 
5. Histomorphometric analysis of bone forma-
tion 
Histomorphometric analysis of bone formation 
in the defect revealed that both -TCPs induced 
greater bone formation than that in control group 
within 4 wk, with negligible difference between 
the two -TCPs (Fig. 7). At 12 wk after implan-
tation, new bone formation in the -TCP200 
samples was significantly greater than that in the 
-TCP600 samples.  
 
Fig. 7  Histomorphometric analysis of new bone formation induced by -TCP implantation.
Data show the mean with standard deviation (N=4). *P < 0.05: Significant difference between
-TCP200 and -TCP600 at 12 wk (ANOVA with Tukey-Kramer test). 
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6. Hydrolysis of -TCP particles in vivo 
Fig. 2B and C show the XRD patterns of the im-
planted -TCPs particles at 4 wk after implanta-
tion. A gentle bulge could be observed around 
30–33o for -TCP200, which is similar to the 
pattern reported for apatite [6] (Fig. 2B and C). 
The specific peak of apatite could be observed at 
32.9o in the pattern of implanted -TCP200. 
There was a subtle change in the pattern for im-
planted -TCP600, suggesting that -TCP200 
converted faster than -TCP600.  
 
Discussion 
-TCP is widely considered as a candidate for 
use as bone grafting material. However, few 
studies have investigated the relationship be-
tween -TCP particle size and its bone-        
formation ability. In the present study, we pre-
sent evidence that -TCP200 induced superior 
bone formation compared with -TCP600 in the 
critical-sized defect of mouse calvaria. The dif-
ference was more obvious at 12 wk after im-
plantation. We did not observe any inflammation 
at 4 and 12 wk, suggesting that both -TCPs 
must be adequately biocompatible as bone graft 
scaffolds.  
Although the effect of inter-particle size, 
corresponding with pore size, on bone formation 
is still controversial, values above 100 m have 
been proposed as a preferable condition for bone 
formation using CaP [20]. Consistent with this 
report, Galois et al. have reported that HA with 
45–80 m pore size induced inferior bone for-
mation speed compared with HA with larger 
pore sizes (80–140, 140–200, and 200–250 m) 
in femoral condyles of rabbits [24]. Furthermore, 
our pervious study using OCP particles showed 
that large particles (500–1000 m), with in-
ter-particle size 176.6 m, induced greater bone 
formation than did small particles (53–300 m), 
with inter-particle size 28.8 m [18]. In the pre-
sent study, inter-particle size of -TCP200 (27 
m) was smaller than that of -TCP600 (209 
m) before implantation (Fig. 3). The bone- 
formation capability of -TCP was hardly af-
fected by its small inter-particle size. There was 
enough cell invasion in the -TCP200-     
implanted site at 12 wk (Fig. 5). This discrep-
ancy might be due to the high biodegradability 
of -TCP. Kihara et al reported that -TCP 
gradually degrades in the bone defect [9], 
suggesting that the inter-particle size of -TCP 
was likely to increase with time after 
implantation. These results indicate that, at the 
time of surgery, inter-particle size over 100 m 
is not always necessary for induction of bone 
regeneration by -TCP particles.   
In the previous study, we have reported that 
the particle size of -TCP in the artificial colla-
gen sponge modified the bone-formation capa-
bility of the scaffold in skull defect in mini-pigs. 
Three different-sized particles were used for the 
experiment (small, 136.2 m; large, 580.8 m; 
large and small mixed, 499.3 m) [1]. The 
mixed particles yielded superior bone formation 
than the other two. Given the amount of artificial 
collagen was same in all three scaffolds, pore 
size distribution would be approximately similar 
among the samples, suggesting that other prop-
erties of -TCP might influence its bone forma-
tion ability. In this study, -TCP200, the smaller 
particle, showed better bone-formation ability 
than the large particle (-TCP600) (Fig. 7). Al-
though we could not elucidate the complete 
mechanism, hydrolysis behavior of -TCPs 
might be partially involved in the process. As 
shown in Fig. 2, -TCP200 transformed to apa-
tite faster than -TCP600 even in vivo. Hydroly-
sis of -TCP is known to alter the concentration 
of calcium and phosphate ions around the crys-
tals [6]. The ions can modulate osteoblast dif-
ferentiation and proliferation of stem cells [25, 
26]. Furthermore, Liu et al reported that ade-
quate amount of -TCP induced osteoblasto-
genesis [15]. The faster hydrolysis of -TCP200 
might provide an appropriate environment for 
the cells to differentiate into bone cells or to 
form new bone.  
In the present study, we could not observe 
well-crystallized apatite XRD pattern at 10.8° 
even in the -TCP200 samples, although there 
were differences around 32° after transplantation 
in vivo. The hydrolysis velocity of -TCP200 
seems to be slower than that reported by other 
studies performed in vitro [6] (Fig. 2). This at-
tenuation of hydrolysis might be due to the ad-
sorption of the protein in the body fluid. A pre-
vious study showed that FBS effectively delayed 
Tokuda et al.-TCP Particle Size and Bone Formation, Nano Biomedicine 7(2), 63-71, 2015 
 70
the hydrolysis of -TCP in the culture medium 
[27]. The various proteins in serum are known to 
modulate nucleation of calcium phosphate [28]. 
It is suggested that the serum contained various 
growth factors or other factors capable of con-
trolling cell fate [29]. Different crystal phase 
induces distinct protein adsorption on products 
[30]. In the present study, hydrolysis of 
-TCP200 likely changed its surface character, 
causing different proteins to be attracted. These 
adsorbed proteins could have contributed to the 
enhanced bone-formation capability of 
-TCP200. 
The present study showed that the bone- 
formation capability of-TCP200 is superior to 
that of -TCP600 in critical-sized defect of 
mouse calvaria. However, the experiment was 
performed under conditions of limitations. The 
-TCP particles used possessed macropores at 
the surface. Surface characters of materials are 
known to affect the results of bone formation. 
Different-sized particles might be necessary for 
obtaining optimal bone regeneration at different 
transplantation sites. It is still unclear how the 
cells responded to the hydrolysis of -TCPs in 
vitro. Our results provide insights into the us-
ability of -TCP particles in bone regeneration 
therapy. However, in view of the above-    
mentioned issues, further detailed examination 
would be essential to determine the optimal size 
of -TCP particles for application in clinical 
practice. 
 
Conclusion  
In the present study, two -TCPs with different 
particle sizes induced distinct bone formation in 
critical-sized bone defect of mouse calvaria. 
These two -TCPs showed different hydrolysis 
behaviors at 4 wk after implantation. These re-
sults indicate that the particle size of -TCPs 
may affect their bone-formation capability. The 
influence of particle size could partially be due 
to the difference in the hydrolysis rate of the 
different-sized -TCP particles.  
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